±íÒÅ´«Ñ§,epigeneticsÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
·úÄòÜÕ,floxuridineÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
BRCA1»ùÒò,BRCA1 geneÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÂÌ,GreenÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
°£ÂÞÌæÄá,erlotinibÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¹í¾ÊÒÒ²æß°,etoposideÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ĤÁªµ°°×,annexinÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
GA_3,GA3Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ«
´ÅÐÔÖ¬ÖÊÌå,magnetoliposomesÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
C-ÔåÀ¶µ°°×,C-phycocyaninÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¸Îϸ°û/´úл,hepatocellular/metabolismÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¸Îϸ°ûÐÔ,hepatocellularÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Ѫ¹ÜÍâÆ¤Áö,HemangiopericytomaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Ѫ¹ÜÄÚÆ¤ÒÖÖÆËØ,endostatinÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
»·ÑõË®ºÏøÀà,cyclooxygenaseÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¦Á-Á¬½ÓËØ,¦Á-cateninÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
賦¼äÖÊÁö,gastrointestinal stromal tumorÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÍØÆËÒ칹ø¢ò,topoisomerase ¢òÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
²¥É¢,DisseminationÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
õ×µ°°×,TalinÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¼×»ù×ªÒÆÃ¸Àà,MethyltransferasesÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¸ÆÕ³µ°°×,cadherinÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Ô¶´¦×ªÒÆ,Distant metastasisÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
µ¨¹Ç»¯´¼,cholecalciferolÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
³Ì¶È,DegreeÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÆøÏàÉ«Æ×/ÖÊÆ×ÁªÓÃÒÇ,GC/MSÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
»¯ÁÆË¨ÈûÊõ,ChemoembolizationÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÒÖ°©»ùÒòPTEN,PTENÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÒÖÖÆµ°°×Àà,arrestinsÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¦Â-ÆÏÌÑÌÇÈ©Ëáø,¦Â-glucuronidaseÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Éñ¾½ÚÁö,ganglioneuromaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ºÚÉ«ËØÁö/Õï¶Ï,melanoma/diagnosisÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¼ªÎ÷Ëû±ö,gemcitabineÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
»¯ÁÆÒ©ÎïÃô¸ÐÐÔ,ChemosensitivityÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÇàÄêÆÚ,YouthÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÏÙÁö/Õï¶Ï,Adenoma/diagnosisÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÐÅʹ/ѪҺ,messenger/bloodÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¶¡ËáÑÎÀà,ButyratesÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Íв´Ì濵,topotecanÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÃâÒßÓ«¹â»¯Ñ§,immunofluorescenceÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
·úÍÑÑõÆÏÌÑÌÇ,FluorodeoxyglucoseÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÉÏÆ¤Ï¸°û¸Æð¤µ°°×,E-cadherinÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
·ÖÃÚµ°°×ÖÊ×é,secretomeÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÒÈĸϸ°ûÁö,pancreatoblastomaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
PÌǵ°°×Àà,P-glycoproteinsÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Âݸ˾úÊô,HelicobacterÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
êÚÃÅ/Íâ¿ÆÑ§,cardia/surgeryÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
·Û·À¼º¼î/Ò©Àíѧ,Tetrandrine/pharmacologyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÁܰÍÁö/²¡Àíѧ,lymphoma/pathologyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Ñõ»¯Å¼µª¼×Íé,azoxymethaneÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÔÙ±í´ï,Re-expressionÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ËÕµ¤ºì¢ñºÅ,Sudan¢ñÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
»ÆÇúÃ¹ËØ,AflatoxinÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
²ñºúÔíß°,SaikosaponinÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Ò¶ÂÌËá,ChlorophyllinÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
·ÅÉäÃâÒß¼ì²â,RadioimmunodetectionÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÂÌŧ¸Ë¾úÍâ¶¾ËØA,PEAÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
»Ø³¦Ôì¿ÚÊõ,ileostomyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Á×Ö¬õ£¼¡´¼µ°°×¾ÛÌÇ-3,glypican-3Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¼ÙÐÔÕ³ÒºÁö,pseudomyxomaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
T·ÖÆÚ,T stagingÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
΢Ѫ¹ÜÐγÉ,angiogenesisÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¶ñÐԳ̶È,MalignancyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¦ÂÁ¬»·ËØ,¦Â-cateninÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÉúÎïѧ/ѪҺ,biological/bloodÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÏÙ°©/Õï¶Ï,Adenocarcinoma/diagÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
˨ÈûÁÆ·¨,EmbolizationÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÒȵºËØÑùÉú³¤Òò×Ó2,Insulin-like growth factor 2Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¹â¶¯Á¦Ñ§ÖÎÁÆ,Photodynamic therapyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÉÏÆ¤Ð͸Æð¤¸½ËØ,E-cadherinÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
»¯Ñ§¸ÐÊÜÆ÷Áö,ChemodectomaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÌìÆÕÂå°²,UlinastatinÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÐÅʹ/·ÖÎö,messenger/analysisÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
MRP,MRP¢òÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
EPA,Ethernet for plant automation(EPA)Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¦Â-ºúÂÞ²·ËØ,¦Â-caroteneÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÉúÌ¬ÓªÑø,eco-nutritionÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
»¯Ñ§Ç÷»¯Òò×ÓÀà,ChemokinesÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÄÚ·ÖÃÚÖÎÁÆ,Endocrine therapyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÍâÃÚÌå,exosomeÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¹ÜÄÚ,intraductalÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
·ÅÉ俹¾ÜÐÔ,RadioresistanceÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÌÇÀ࿹ÔCA19-9,CA19-9Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Rbµ°°×,Rb proteinÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÇÐÔµ,MarginÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¶ñÐÔÖ×ÁöÏà¹ØÎïÖÊ,TSGFÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Ö×ÁöÌØÒìÐÔ,tumor-specificÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÒÈθÎǺÏ,PancreaticogastrostomyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Êý×ÖѪ¹Ü¼õÓ°,DSAÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
15-Ö¬ÑõºÏø-1,15-lipoxygenase-1Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÈâÁö/Õï¶Ï,Sarcoma/diagnosisÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Ö×Áö/Íâ¿ÆÊÖÊõ,neoplasms/surgeryÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ɸѡÊÔÑé,Screening testÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÈéÍ·×´Áö/Õï¶Ï,Papilloma/diagnosisÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¸Æð¤ËØ,CadherinÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÔçÆÚÉú³¤·´Ó¦Òò×Ó-1,EGR-1Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ«
TACEÊõ,TACEÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÄϹϵ°°×,CucurmosinÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
²¡¶¾ÖÎÁÆ,virotherapyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÄÚ·ÅÁÆ,brachytherapyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«

|